1005 related articles for article (PubMed ID: 29325362)
21. Radiomics of Late Gadolinium Enhancement Reveals Prognostic Value of Myocardial Scar Heterogeneity in Hypertrophic Cardiomyopathy.
Fahmy AS; Rowin EJ; Jaafar N; Chan RH; Rodriguez J; Nakamori S; Ngo LH; Pradella S; Zocchi C; Olivotto I; Manning WJ; Maron M; Nezafat R
JACC Cardiovasc Imaging; 2024 Jan; 17(1):16-27. PubMed ID: 37354155
[TBL] [Abstract][Full Text] [Related]
22. Clinical, echocardiographic and cardiac MRI predictors of outcomes in patients with apical hypertrophic cardiomyopathy.
Yin Y; Hu W; Zhang L; Wu D; Yang C; Ye X
Int J Cardiovasc Imaging; 2022 Mar; 38(3):643-651. PubMed ID: 34652588
[TBL] [Abstract][Full Text] [Related]
23. Left atrial and left ventricular strain in feature-tracking cardiac magnetic resonance for predicting patients at high risk of sudden cardiac death in hypertrophic cardiomyopathy.
Zhu X; Shi Y; Lian J; Shen H; Li L; Wu H; Tian Y; Liu P
Quant Imaging Med Surg; 2024 May; 14(5):3544-3556. PubMed ID: 38720852
[TBL] [Abstract][Full Text] [Related]
24. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
Rubinshtein R; Glockner JF; Ommen SR; Araoz PA; Ackerman MJ; Sorajja P; Bos JM; Tajik AJ; Valeti US; Nishimura RA; Gersh BJ
Circ Heart Fail; 2010 Jan; 3(1):51-8. PubMed ID: 19850699
[TBL] [Abstract][Full Text] [Related]
25. Improvement in sudden cardiac death risk prediction by the enhanced American College of Cardiology/American Heart Association strategy in Chinese patients with hypertrophic cardiomyopathy.
Liu J; Wu G; Zhang C; Ruan J; Wang D; Zhang M; Wang L; Yang Y; Li X; Wang Y; Hui R; Zou Y; Kang L; Wang J; Song L
Heart Rhythm; 2020 Oct; 17(10):1658-1663. PubMed ID: 32311532
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Role of Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Low-to-Intermediate Sudden Cardiac Death Risk Score.
Todiere G; Nugara C; Gentile G; Negri F; Bianco F; Falletta C; Novo G; Di Bella G; De Caterina R; Zachara E; Re F; Clemenza F; Sinagra G; Emdin M; Aquaro GD
Am J Cardiol; 2019 Oct; 124(8):1286-1292. PubMed ID: 31447011
[TBL] [Abstract][Full Text] [Related]
27. Prediction of sudden death risk in obstructive hypertrophic cardiomyopathy: Potential for refinement of current criteria.
Desai MY; Smedira NG; Dhillon A; Masri A; Wazni O; Kanj M; Sato K; Thamilarasan M; Popovic ZB; Lever HM
J Thorac Cardiovasc Surg; 2018 Aug; 156(2):750-759.e3. PubMed ID: 29735354
[TBL] [Abstract][Full Text] [Related]
28. Long-term risk of sudden cardiac death in hypertrophic cardiomyopathy: a cardiac magnetic resonance outcome study.
Greulich S; Seitz A; Herter D; Günther F; Probst S; Bekeredjian R; Gawaz M; Sechtem U; Mahrholdt H
Eur Heart J Cardiovasc Imaging; 2021 Jun; 22(7):732-741. PubMed ID: 33458753
[TBL] [Abstract][Full Text] [Related]
29. Late gadolinium enhancement is common in patients with hypertrophic cardiomyopathy and no clinical risk factors for sudden cardiac death: A single center experience.
Lyons KS; Dixon LJ; Johnston N; Noad R; Hamilton A; McKeag N; Horan P
Cardiol J; 2014; 21(1):29-32. PubMed ID: 23990187
[TBL] [Abstract][Full Text] [Related]
30. Assessment of late gadolinium enhancement in hypertrophic cardiomyopathy improves risk stratification based on current guidelines.
Wang J; Yang S; Ma X; Zhao K; Yang K; Yu S; Yin G; Dong Z; Song Y; Cui C; Li J; Wang C; Hao J; Lu M; Chen X; Zhao S
Eur Heart J; 2023 Dec; 44(45):4781-4792. PubMed ID: 37795986
[TBL] [Abstract][Full Text] [Related]
31. Extent of late gadolinium enhancement at right ventricular insertion points in patients with hypertrophic cardiomyopathy: relation with diastolic dysfunction.
Zhu Y; Park EA; Lee W; Kim HK; Chu A; Chung JW; Park JH
Eur Radiol; 2015 Apr; 25(4):1190-200. PubMed ID: 25597022
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness of the 2014 European Society of Cardiology guideline on sudden cardiac death in hypertrophic cardiomyopathy: a systematic review and meta-analysis.
O'Mahony C; Akhtar MM; Anastasiou Z; Guttmann OP; Vriesendorp PA; Michels M; Magrì D; Autore C; Fernández A; Ochoa JP; Leong KMW; Varnava AM; Monserrat L; Anastasakis A; Garcia-Pavia P; Rapezzi C; Biagini E; Gimeno JR; Limongelli G; Omar RZ; Elliott PM
Heart; 2019 Apr; 105(8):623-631. PubMed ID: 30366935
[TBL] [Abstract][Full Text] [Related]
33. Late gadolinium enhancement entropy as a new measure of myocardial tissue heterogeneity for prediction of adverse cardiac events in patients with hypertrophic cardiomyopathy.
Gu ZY; Qian YF; Chen BH; Wu CW; Zhao L; Xue S; Zhao L; Wu LM; Wang YY
Insights Imaging; 2023 Aug; 14(1):138. PubMed ID: 37603140
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of myocardial extracellular volume fraction evaluation based on cardiac magnetic resonance T1 mapping with T1 long and short in hypertrophic cardiomyopathy.
Li Y; Liu X; Yang F; Wang J; Xu Y; Fang T; Pu L; Zhou X; Han Y; Chen Y
Eur Radiol; 2021 Jul; 31(7):4557-4567. PubMed ID: 33449190
[TBL] [Abstract][Full Text] [Related]
35. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD).
O'Mahony C; Jichi F; Pavlou M; Monserrat L; Anastasakis A; Rapezzi C; Biagini E; Gimeno JR; Limongelli G; McKenna WJ; Omar RZ; Elliott PM;
Eur Heart J; 2014 Aug; 35(30):2010-20. PubMed ID: 24126876
[TBL] [Abstract][Full Text] [Related]
36. Validation of the hypertrophic cardiomyopathy risk-sudden cardiac death calculator in Asians.
Choi YJ; Kim HK; Lee SC; Park JB; Moon I; Park J; Kim YJ; Sohn DW; Ommen S
Heart; 2019 Dec; 105(24):1892-1897. PubMed ID: 31383719
[TBL] [Abstract][Full Text] [Related]
37. Management and outcomes of hypertrophic cardiomyopathy in young adults.
Baron É; Karam N; Donal E; Puscas T; Mirabel M; Bacher A; Wahbi K; Mazzella JM; Jeunemaitre X; Reant P; Hagège A;
Arch Cardiovasc Dis; 2021; 114(6-7):465-473. PubMed ID: 33744178
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of left ventricular end diastolic pressure using E/E' in patients with hypertrophic cardiomyopathy.
Badran HM; Soltan G; Almeleigi R; Faheem N; Yacoub MH
Echocardiography; 2019 Dec; 36(12):2167-2175. PubMed ID: 31742769
[TBL] [Abstract][Full Text] [Related]
39. Assessment of the association between the presence of fragmented QRS and the predicted risk score of sudden cardiac death at 5 years in patients with hypertrophic cardiomyopathy.
Özyılmaz S; Akgül Ö; Uyarel H; Pusuroğlu H; Karayakalı M; Gül M; Çetin M; Satılmışoğlu H; Yıldırım A; Bakır İ
Anatol J Cardiol; 2017 Jul; 18(1):54-61. PubMed ID: 28559533
[TBL] [Abstract][Full Text] [Related]
40. CMR assessment and clinical outcomes of hypertrophic cardiomyopathy with or without ventricular remodeling in the end-stage phase.
Cheng S; Choe YH; Ota H; Cui C; Yin G; Lu M; Li L; Chen X; Prasad SK; Zhao S
Int J Cardiovasc Imaging; 2018 Apr; 34(4):597-605. PubMed ID: 29071521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
